Cel
Diabetic retinopathy (DR), the leading cause of blindness among working-age individuals in developed countries has been classically considered to be a microcirculatory disease of the retina. However, there is growing evidence to suggest that retinal neurodegeneration is an early event in the pathogenesis of DR. For this reason, it is reasonable to hypothesize that therapeutic strategies based on neuroprotection will be effective not only in preventing or arresting retinal neurodegeneration but also in preventing the development and progression of the early stages of DR (ie. microaneurysms and/or retinal thickness).
EUROCONDOR (European Consortium for the Early Treatment of Diabetic Retinopathy) is a solid and well balanced consortium (ophthalmologists, endocrinologists, basic researchers) which has been created in order to implement the first clinical trial using eye drops for treatment of the early stages of DR. The participants are top leaders in their field and central readings will be performed by the Coordinating Centre of the European Vision Institute Clinical Research Network (EVICR.Net).
The main objectives of the project are the following:
Primary objective: To assess whether the selected neuroprotective drugs (brimonidine and somatostatin) administered topically are able to prevent or arrest neurodegeneration, as well as the development and progression of the early stages of DR.
Secondary objectives: 1) To determine the prevalence of functional abnormalities related to neurodegeneration in those patients without or with minimal microvascular damage under ophthalmoscopic examination. 2) To compare the effectiveness of the selected drugs. 3) To evaluate the local and systemic adverse effects of the selected drugs. 4) To identify those patients most prone to progressive worsening (characterization of phenotypes and circulating biomarkers). 5) To determine the molecular mechanisms by which the selected drugs exert their beneficial effects.
Dziedzina nauki
Temat(-y)
Zaproszenie do składania wniosków
FP7-HEALTH-2011-two-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
08035 Barcelona
Hiszpania
Zobacz na mapie
Uczestnicy (17)
3000 548 Coimbra
Zobacz na mapie
5230 Odense M
Zobacz na mapie
89081 Ulm
Zobacz na mapie
20132 Milano
Zobacz na mapie
35122 Padova
Zobacz na mapie
GL53 7AN CHELTENHAM
Zobacz na mapie
08007 Barcelona
Zobacz na mapie
EC1V 2PD London
Zobacz na mapie
75012 Paris
Zobacz na mapie
L69 7ZX Liverpool
Zobacz na mapie
B4 7ET Birmingham
Zobacz na mapie
10124 Torino
Zobacz na mapie
46012 Valencia
Zobacz na mapie
28006 Madrid
Zobacz na mapie
1090 Bruxelles / Brussel
Zobacz na mapie
08777 SANTA QUINTI DE MEDIONA
Zobacz na mapie
Zakończenie uczestnictwa
28029 MADRID
Zobacz na mapie